Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: A pilot study

European Journal of Nuclear Medicine

Volumn 26, Issue 5, 1999, Pages 499-503

  Stokkel, Marcel P M ^a   Ten Broek, Frans Willem ^b   Van Rijk, Peter P ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Fluorine 18 fluorodeoxyglucose; Head and neck cancer; MCD; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER SCINTISCANNING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION;

EID: 0032895237     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050417     Document Type: Article

References (23)

1. 1. Visser O, Boebergh JWW, Schouten LJ. Incindence of cancer in The Netherlands 1991. Third report of the Netherlands Cancer Registry, Utrecht, 1994.
2. 2. Snow GB, Patel P, Leemans CR, Tiwari R. Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otolaryngol 1992; 249: 187-194.
3. 3. McLaughlin MP, Mendenhall WM, Mancuso AA, et al. Retropharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neck. Head Neck 1995; 17: 190-198.
4. 4. Ali S, Tiwari RM, Snow GB. False positive and false-negative neck nodes. Head Neck Surg 1985; 8: 78-82.
5. 5. Hillsamer PJ, Schuller DE, McGhee RB, Chakeres D, Young DC. Improving diagnostic accuracy of cervical metastases with computed tomography and magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 1990; 116: 1297-1301.
6. 6. van den Brekel MWM, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990; 177: 379-384.
7. 7. Dillon WP, Harnsberger HR. The impact of radiologic imaging on staging of cancer of the head and neck. Semin Oncol 1991; 18: 64-79.
8. 8. Quetz Ju, Rohr S, Hoffmann P, Wustrow J, Mertens J. B-image sonography in lymph node staging of the head and neck area. A comparison with palpation, computerized and magnetic resonance tomography. HNO 1991; 39: 61-63.
9. 9. Van den Brekel MWM, Catelijns JA, Croll GA, et al. Magnetic resonance imaging versus palpation of cervical lymph node metastases. Arch Otolaryngol Head Neck Surg 1991; 117: 666-673.
10. 10. Van den Brekel MWM, Castelijns JA, Stel HV, et al. Occult metastatic neck disease: detection with ultrasound and ultra-sound guided fine needle aspiration cytology. Radiology 1991; 178: 457-461.
11. 11. Shah JP. Cervical lymph node metastases - diagnostic, therapeutic and prognostic implications. Oncology 1990; 4: 61-69.
12. 12. Engel H, Steinert H, Buck A, Berthold T, Boni AH, von Schulthess GK. Whole-body PET: physiological and artifactual fluordeoxyglucose accumulations. J Nucl Med 1996; 37: 441-446.
13. 13. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186: 27-35.
14. 14. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Hoh C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumours and assessment of cervical adenopathy. Laryngoscope 1992; 102: 281-288.
15. 15. Mukherji SK, Drane WE, Mancuso AA, Parsons JT, Mendenhall WM, Stringer S. Occult primary tumours of the head and neck: detection with 2-[F-18]fluoro-2-deoxy-D-glucose SPET. Radiology 1996; 199: 761-766.
16. 16. Braams JW, Pruim J, Kole AC, et al. Detection of unknown primary head and neck tumours by positron emission tomography. Int J Oral Maxillofac Surg 1997; 26: 112-115.
17. 17. Braams JW, Pruim J, Freling NJM, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995; 36: 211-216.
18. 18. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995; 36: 1747-1757.
19. 19. Abdel-Nabi H, Spaulding MB, Behar P, Nguyen A, Simpson G, Gona J. Value of PET-FDG imaging in the pre-operative work-up of patients with head and neck carcinomas. J Nucl Med 1996; 37: 136P.
20. 20. Manolidis S, Isaacs RS, Valk PE, Pounds R, Abella-Columna E, Donald PJ. Staging head and neck cancer by whole-body PET-FDG imaging. J Nucl Med 1996; 37: 136P.
21. 21. McGuirt WF, Williams DW, Keyes JW, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995; 105: 373-375.
22. 22. McGuirt WF, Greven KM, Keyes JW, et al. Positron emission tomography in the evaluation of laryngeal carcinoma. Ann Otol Rhinol Laryngol 1995; 104: 274-278.
23. 23. Benchaou M, Lehmann W, Slosman DO, et al. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol 1996; 116: 332-335.